Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes

被引:98
作者
Hanecak, R
BrownDriver, V
Fox, MC
Azad, RF
Furusako, S
Nozaki, C
Ford, C
Sasmor, H
Anderson, KP
机构
[1] ISIS PHARMACEUT,DEPT OLIGONUCLEOTIDE CHEM,CARLSBAD,CA 92008
[2] CHEMO SERO THERAPEUT RES INST,DEPT MOLEC GENET,KUMAMOTO 86912,JAPAN
关键词
D O I
10.1128/JVI.70.8.5203-5212.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Genetic and biochemical studies have provided convincing evidence that the 5' noncoding region (5' NCR) of hepatitis C virus (HCV) is highly conserved among viral isolates worldwide and that translation of HCV is directed by an internal ribosome entry site (IRES) located within the 5' NCR. We have investigated inhibition of HCV gene expression using antisense oligonucleotides complementary to the 5 NCR, translation initiation codon, and core protein coding sequences. Oligonucleotides were evaluated for activity after treatment of a human hepatocyte cell line expressing the HCV 5' NCR, core protein coding sequences, and the majority of the envelope gene (El). More than 50 oligonucleotides were evaluated for inhibition of HCV RNA and protein expression. Two oligonucleotides, ISIS 6095, targeted to a stem-loop structure within the 5' NCR known to be important for IRES function, and ISIS 6547, targeted to sequences spanning the AUG used for initiation of HCV polyprotein translation, were found to be the most effective at inhibiting HCV gene expression. ISIS 6095 and 6547 caused concentration-dependent reductions in HCV RNA and protein levels, with 50% inhibitory concentrations of 0.1 to 0.2 mu M. Reduction of RNA levels, and subsequently protein levels, by these phosphorothioate oligonucleotides was consistent with RNase H cleavage of RNA at the site of oligonucleotide hybridization. Chemically modified HCV antisense phosphodiester oligonucleotides mere designed and evaluated for inhibition of core protein expression to identify oligonucleotides and HCV target sequences that db not require RNase H activity to inhibit expression. A uniformly modified 2'-methoxyethoxy phosphodiester antisense oligonucleotide complementary to the initiator AUG reduced HCV core protein levels as effectively as phosphorothioate oligonucleotide ISIS 6095 but without reducing HCV RNA levels. Results of our studies show that HCV gene expression is reduced by antisense oligonucleotides and demonstrate that it is feasible to design antisense oligonucleotide inhibitors of translation that do not require RNase H activation. The data demonstrate that chemically modified antisense oligonucleotides can be used as tools to identify important regulatory sequences and/or structures important for efficient translation of HCV.
引用
收藏
页码:5203 / 5212
页数:10
相关论文
共 53 条
[1]   OLIGODEOXYNUCLEOSIDE PHOSPHORAMIDATES AND PHOSPHOROTHIOATES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS [J].
AGRAWAL, S ;
GOODCHILD, J ;
CIVEIRA, MP ;
THORNTON, AH ;
SARIN, PS ;
ZAMECNIK, PC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (19) :7079-7083
[2]   INHIBITION OF VESICULAR STOMATITIS-VIRUS PROTEIN-SYNTHESIS AND INFECTION BY SEQUENCE-SPECIFIC OLIGODEOXYRIBONUCLEOSIDE METHYLPHOSPHONATES [J].
AGRIS, CH ;
BLAKE, KR ;
MILLER, PS ;
REDDY, MP ;
TSO, POP .
BIOCHEMISTRY, 1986, 25 (20) :6268-6275
[3]  
ALT M, 1995, HEPATOLOGY, V22, P707
[4]   DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS IN PROSPECTIVELY FOLLOWED TRANSFUSION RECIPIENTS WITH ACUTE AND CHRONIC NON-A-HEPATITIS, NON-B-HEPATITIS [J].
ALTER, HJ ;
PURCELL, RH ;
SHIH, JW ;
MELPOLDER, JC ;
HOUGHTON, M ;
CHOO, QL ;
KUO, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1494-1500
[5]   ANTIVIRAL ACTIVITY OF A PHOSPHOROTHIOATE OLIGONUCLEOTIDE COMPLEMENTARY TO RNA OF THE HUMAN CYTOMEGALOVIRUS MAJOR IMMEDIATE-EARLY REGION [J].
AZAD, RF ;
DRIVER, VB ;
TANAKA, K ;
CROOKE, RM ;
ANDERSON, KP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) :1945-1954
[6]  
Baker B., UNPUB
[7]  
BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
[8]   SECONDARY STRUCTURE OF THE 5' NONTRANSLATED REGIONS OF HEPATITIS-C VIRUS AND PESTIVIRUS GENOMIC RNAS [J].
BROWN, EA ;
ZHANG, HC ;
PING, LH ;
LEMON, SM .
NUCLEIC ACIDS RESEARCH, 1992, 20 (19) :5041-5045
[9]  
BRUIX J, 1989, LANCET, V2, P1004
[10]   AT LEAST 12 GENOTYPES OF HEPATITIS-C VIRUS PREDICTED BY SEQUENCE-ANALYSIS OF THE PUTATIVE E1-GENE OF ISOLATES COLLECTED WORLDWIDE [J].
BUKH, J ;
PURCELL, RH ;
MILLER, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :8234-8238